CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $637,321 | -79.6% | 14,041 | -74.8% | 0.00% | -83.3% |
| Q2 2023 | $3,130,535 | +28.1% | 55,763 | +3.2% | 0.01% | +50.0% |
| Q1 2023 | $2,444,727 | +19.0% | 54,051 | +6.9% | 0.00% | 0.0% |
| Q4 2022 | $2,054,939 | -37.5% | 50,552 | +0.4% | 0.00% | -42.9% |
| Q3 2022 | $3,290,000 | +98.6% | 50,343 | +84.6% | 0.01% | +250.0% |
| Q2 2022 | $1,657,000 | -3.2% | 27,272 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $1,711,000 | -47.8% | 27,272 | -36.8% | 0.00% | -50.0% |
| Q4 2021 | $3,277,000 | -30.4% | 43,137 | +2.6% | 0.00% | -50.0% |
| Q3 2021 | $4,707,000 | -56.1% | 42,062 | -36.5% | 0.00% | -55.6% |
| Q2 2021 | $10,725,000 | +240.9% | 66,248 | +156.5% | 0.01% | +200.0% |
| Q1 2021 | $3,146,000 | -6.9% | 25,827 | +17.1% | 0.00% | 0.0% |
| Q4 2020 | $3,379,000 | -3.0% | 22,064 | -73.1% | 0.00% | -40.0% |
| Q1 2020 | $3,483,000 | +69.2% | 82,123 | +142.9% | 0.01% | +150.0% |
| Q4 2019 | $2,059,000 | +25.9% | 33,807 | -14.8% | 0.00% | 0.0% |
| Q3 2019 | $1,636,000 | -42.4% | 39,676 | -34.2% | 0.00% | -33.3% |
| Q2 2019 | $2,838,000 | -0.1% | 60,270 | -24.2% | 0.00% | 0.0% |
| Q1 2019 | $2,840,000 | +62.1% | 79,516 | +27.5% | 0.00% | +50.0% |
| Q4 2018 | $1,752,000 | -34.0% | 62,352 | +4.2% | 0.00% | 0.0% |
| Q3 2018 | $2,653,000 | -64.0% | 59,825 | -52.3% | 0.00% | -71.4% |
| Q2 2018 | $7,372,000 | -30.7% | 125,457 | -46.1% | 0.01% | -30.0% |
| Q1 2018 | $10,639,000 | +95.2% | 232,744 | +0.3% | 0.01% | +150.0% |
| Q4 2017 | $5,449,000 | +128.6% | 232,060 | +74.0% | 0.00% | +100.0% |
| Q3 2017 | $2,384,000 | – | 133,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |